An unknown input observer-EFIR combined estimator for electro-hydraulic actuator in sensor fault tolerant control application

This paper presents a novel unknown input observer (UIO) integrated extended finite impulse response (EFIR) estimator (UIOEFIR) and its application for an effective sensor fault tolerant control of an electro-hydraulic-actuator (EHA). The proposed estimator exploits the UIO structure in the EFIR filter. Thus, it requires only a small number of historical data (N) whilst ensuring threefold: i) Sensor fault and system-state estimation accuracy under time-correlated noise ii) The number of estimator-design-parameters is significantly minimized. iii) Robust residual generation. A Lyapunov-stability-based theory is carried out to study its convergence condition. Next, an EHAbased test rig has been setup and sensor FTC is performed by carrying this estimator as a part of fault diagnosis algorithm to evaluate its performance by both simulation and realtime experiments. Results highlight that under optimal setting (N = Nopt), the estimator performance is near-accurate to the very-well-developed Extended Kalman Filter-based unknown input observer in an undisturbed condition but significantly outperformed while dealing with time-correlated noise under the same control environment. The estimator also shows its robustness under below-optimal setting (downgrading Nopt by 50%.) while performing in real-time sensor fault-tolerant control

Systems biology approach in the development of chemically-defined media for production of protein therapeutics in Chinese hamster ovary cells

Cell culture medium plays a critical role on mammalian cell growth, protein expression and quality. Typical cell culture medium formulations consist of \u3e50 components which include amino acids, vitamins, trace metals, lipids and proteins. Chinese Hamster Ovary (CHO) cells that produce biotherapeutics are propagated in specific cell culture media to ensure robust productivity and product quality. Systems biology has been applied to multiple areas of biological research to gain a better understanding of disease origins and to identify potential new drug targets. Although CHO cells are simpler systems, they share similar biochemistry and cellular pathways. Therefore, leveraging the systems biology knowledge from animal systems and applying these strategic systems biological tools to bioprocess development can be valuable in gaining better understanding of CHO cell culture performance, optimizing cell culture media, and subsequently resulting in better control of the overall production processes. In this presentation, we will present several case studies of various ‘omics tools applied to (1) optimize cell culture medium formulation for improve cell growth and productivity via metabolomics, (2) understand effects of medium components on cellular gene expression via transcriptomics, and on product quality via glycomics, and (3) identify potential cellular protein targets that are affected by stress imposed during production process via proteomics. The development of a statistical model that aims to highlight key metabolites and a machine learning model that identifies significantly important genes which are involved in monoclonal antibody production will also be discussed

LASER: A living analytics experimentation system for large-scale online controlled experiments

National Research Foundation (NRF) Singapore under International Research Centre Funding Initiativ

Inhibition of aminoglycoside 6\u3csup\u3e′\u3c/sup\u3e-n-acetyltransferase type ib (Aac(6\u3csup\u3e′\u3c/sup\u3e )-ib): Structure–activity relationship of substituted pyrrolidine pentamine derivatives as inhibitors

The aminoglycoside 6′-N-acetyltransferase type Ib (AAC(6′ )-Ib) is a common cause of resistance to amikacin and other aminoglycosides in Gram-negatives. Utilization of mixture-based combinatorial libraries and application of the positional scanning strategy identified an inhibitor of AAC(6′ )-Ib. This inhibitor’s chemical structure consists of a pyrrolidine pentamine scaffold substituted at four locations (R1, R3, R4, and R5). The substituents are two S-phenyl groups (R1 and R4), an S-hydroxymethyl group (R3), and a 3-phenylbutyl group (R5). Another location, R2, does not have a substitution, but it is named because its stereochemistry was modified in some compounds utilized in this study. Structure–activity relationship (SAR) analysis using derivatives with different functionalities, modified stereochemistry, and truncations was carried out by assessing the effect of the addition of each compound at 8 µM to 16 µg/mL amikacin-containing media and performing checkerboard assays varying the concentrations of the inhibitor analogs and the antibiotic. The results show that: (1) the aromatic functionalities at R1 and R4 are essential, but the stereochemistry is essential only at R4; (2) the stereochemical conformation at R2 is critical; (3) the hydroxyl moiety at R3 as well as stereoconformation are required for full inhibitory activity; (4) the phenyl functionality at R5 is not essential and can be replaced by aliphatic groups; (5) the location of the phenyl group on the butyl carbon chain at R5 is not essential; (6) the length of the aliphatic chain at R5 is not critical; and (7) all truncations of the scaffold resulted in inactive compounds. Molecular docking revealed that all compounds preferentially bind to the kanamycin C binding cavity, and binding affinity correlates with the experimental data for most of the compounds evaluated. The SAR results in this study will serve as the basis for the design of new analogs in an effort to improve their ability to induce phenotypic conversion to susceptibility in amikacin-resistant pathogens

Performance of the CMS Cathode Strip Chambers with Cosmic Rays

The Cathode Strip Chambers (CSCs) constitute the primary muon tracking device in the CMS endcaps. Their performance has been evaluated using data taken during a cosmic ray run in fall 2008. Measured noise levels are low, with the number of noisy channels well below 1%. Coordinate resolution was measured for all types of chambers, and fall in the range 47 microns to 243 microns. The efficiencies for local charged track triggers, for hit and for segments reconstruction were measured, and are above 99%. The timing resolution per layer is approximately 5 ns

An Inserted α/β Subdomain Shapes the Catalytic Pocket of Lactobacillus johnsonii Cinnamoyl Esterase

Microbial enzymes produced in the gastrointestinal tract are primarily responsible for the release and biochemical transformation of absorbable bioactive monophenols. In the present work we described the crystal structure of LJ0536, a serine cinnamoyl esterase produced by the probiotic bacterium Lactobacillus johnsonii N6.2.We crystallized LJ0536 in the apo form and in three substrate-bound complexes. The structure showed a canonical α/β fold characteristic of esterases, and the enzyme is dimeric. Two classical serine esterase motifs (GlyXSerXGly) can be recognized from the amino acid sequence, and the structure revealed that the catalytic triad of the enzyme is formed by Ser(106), His(225), and Asp(197), while the other motif is non-functional. In all substrate-bound complexes, the aromatic acyl group of the ester compound was bound in the deepest part of the catalytic pocket. The binding pocket also contained an unoccupied area that could accommodate larger ligands. The structure revealed a prominent inserted α/β subdomain of 54 amino acids, from which multiple contacts to the aromatic acyl groups of the substrates are made. Inserts of this size are seen in other esterases, but the secondary structure topology of this subdomain of LJ0536 is unique to this enzyme and its closest homolog (Est1E) in the Protein Databank.The binding mechanism characterized (involving the inserted α/β subdomain) clearly differentiates LJ0536 from enzymes with similar activity of a fungal origin. The structural features herein described together with the activity profile of LJ0536 suggest that this enzyme should be clustered in a new group of bacterial cinnamoyl esterases